Formulation Optimization in a University Hospital: The Example of Pediatric Solutions of the ACE Inhibitor Captopril

Many major drugs are not available in pediatric form. As a result, hospital pharmacists are often requested to provide the medical staff with liquid formulations for individualized dosage and easy administration to newborn and young patients. Such in-house formulations must of course fulfil stringen...

Full description

Saved in:
Bibliographic Details
Published inChimia Vol. 59; no. 6
Main Authors Markoulina Berger-Gryllaki, Grégory Podilsky, Nicolas Widmer, Stéphane Gloor, Bernard Testa, André Pannatier
Format Journal Article
LanguageEnglish
Published Swiss Chemical Society 01.06.2005
Subjects
Captopril
Chemical stability
Formulation
Hplc
Microbial stability
Pharmaceutical technology
Online AccessGet full text

Cover

More Information
Summary:Many major drugs are not available in pediatric form. As a result, hospital pharmacists are often requested to provide the medical staff with liquid formulations for individualized dosage and easy administration to newborn and young patients. Such in-house formulations must of course fulfil stringent criteria of purity and stability. This paper reports the development of a liquid solution of captopril for pediatric use. A specific HPLC-UV method was developed. A number of formulations described in the literature as affording one-month stability were examined and found wanting. A simple solution of the drug (1 mg/ml) in purified water containing 0.1% EDTA-Na proved chemically and microbiologically stable at room temperature for two years.
ISSN:0009-4293
2673-2424
DOI:10.2533/000942905777676362